Respinomycin A2
Respinomycin A2 is an anthracycline antibiotic that causes the differentiation of leukemic K-562 cells[1].
Product Specifications
CAS Number
151233-04-4
UNSPSC
12352005
Target
Antibiotic; Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Smiles
[H][C@@]12OC3=C([C@@](O1)([C@H]([C@H]([C@@H]2O)N(C)C)OC4CC(N)(C(C(O4)C)OC5OC(C(C(C5OC)(C)O)O)C)C)C)C=CC6=C3C(C7=C(C8=C(C[C@@](O)(C(C8)OC)C)C=C7C6=O)O)=O
Molecular Formula
C43H58N2O15
Molecular Weight
842.93
References & Citations
[1]M Ubukata, et al. Respinomycins A1, A2, B, C and D, a novel group of anthracycline antibiotics. II. Physico-chemical properties and structure elucidation. J Antibiot (Tokyo) . 1993 Jun;46 (6) :942-51.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040580-100 1x 100 µL
Histone H1 (1415-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
